[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-351584-105":59,"doc-detail-351584-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","the-efficacy-of-scalp-cooling-in-patients-receiving-chemotherapy-for-primary-gynecologic-cancers-a-randomized-controlled-trial","The efficacy of scalp cooling in patients receiving chemotherapy for primary gynecologic cancers: a randomized controlled trial","","A randomized controlled trial evaluated scalp cooling for preventing chemotherapy-induced alopecia (CIA) in women receiving platinum-based regimens for primary gynecologic cancers, where evidence has been limited. Women scheduled for 3-weekly carboplatin and paclitaxel were randomized 1:1 to scalp cooling or usual clinical practice, with 44 and 42 participants analyzed. Hair preservation (Dean score ≤ 2) was higher with scalp cooling (29.6% vs 0%, p = 0.002), alongside improved global health status and functioning, and lower psychological distress after cycle 2 and follow-up, with no major adverse events.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/the-efficacy-of-scalp-cooling-in-patients-receiving-chemotherapy-for-primary-gynecologic-cancers-a-randomized-controlled-trial/351584/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/the-efficacy-of-scalp-cooling-in-patients-receiving-chemotherapy-for-primary-gynecologic-cancers-a-randomized-controlled-trial/351584.png","ImageObject",300,407,{"name":92,"@type":93},"Rizky","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-11","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the primary goal of the study?","Question",{"text":112,"@type":113},"To assess whether scalp cooling can improve hair preservation after completion of chemotherapy in women with primary gynecologic cancers.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were participants assigned to treatment groups?",{"text":117,"@type":113},"Women planning 3-weekly carboplatin and paclitaxel were randomized 1:1 to scalp cooling or usual clinical practice.",{"name":119,"@type":110,"acceptedAnswer":120},"What effects did scalp cooling have on psychological outcomes?",{"text":121,"@type":113},"Compared with usual practice, the scalp cooling group showed a lower incidence of psychological distress after cycle 2 and lower median PHQ-ADS scores after cycle 2 and 2–3 weeks post-chemotherapy.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},351584,1790196515,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962085564807,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nThe efficacy of scalp cooling inpatients receiving chemotherapy for primary gynecologic cancers: a randomized controlled trial  \nShuk Tak Kwok1,2, Lesley Suk Kwan Lau2, TatOn Chan2, Mandy ManYee Chu1,2,  \nSiew Fei Ngu1,2, Karen Kar Loen Chan1,2, Hextan Yuen Sheung Ngan1,2, Polly Pui Yee Ho1, Lina Wu3, Damaris Suk Mei Hung3, Heidi KaYing Lo4, Christina Sze Man Wong5 &  \nKaYuTse1,2􀀍  \nScalp cooling can prevent chemotherapy-induced alopecia in breast cancer patients. But data in gynecologic patients were scarce. The CHARM study was a single-center randomized study. Women planning for 3-weekly carboplatin and paclitaxel were randomized to either scalp cooling or usual clinical practice in 1:1 ratio. The primary endpoint was the efficacy in hair preservation after the completion of chemotherapy as assessed by the clinicians. Secondary endpoints included quality of life, the incidence of psychological distress, and safety. 142 women were invited to join the study but 56 refused. Finally, 44 women were randomized to the intervention group and 42 to the control group. The successful rate in preserving hair, defined as Dean score ≤ 2, upon completion of chemotherapy was significantly higher in the intervention group (29.6%, 95% confidence interval (CI) 12.4–46.9%) than the control group (0%, 95% CI 0–0%) (p = 0.002) . Compared to the control group, the intervention group had significantly better global health status, physical functioning, and role functioning during the chemotherapy, lower incidence of psychological distress after cycle 2 of chemotherapy (27.8% vs. 62.2%, p = 0.003), and lower median PHQ-ADS scores after cycle 2 (5.5 vs. 11.0, p = 0.045) and 2–3 weeks post-chemotherapy (5.0 vs. 9.0, p = 0.033) . However, the intervention group had a 30% drop-out rate despite no major adverse events. Scalp cooling could reduce the incidence of CIA and potentially alleviate psychological distress and improve the QOL in gynecologic cancer patients. Further effort is needed to improve the acceptance and compliance rates in Asian population.([ClinicalTrials.gov](ClinicalTrials.gov) number, NCT04168242) .  \nKeywords Scalp cooling, Chemotherapy-induced alopecia, Qualify of life, Psychological distress, Gynecologic cancers  \nChemotherapy-induced alopecia (CIA) is a distressing adverse event (AE) in women receiving chemotherapy because it directly affects their self-image1. About 17% of women with gynecologic cancers regarded alopecia asthe most traumatic AE, and up to 14% might refuse curative therapies that are associated with alopecia2. CIA typically starts within 2–4 weeks after the initiation of chemotherapy, and it will advance to complete alopecia in 2–3 months3. In gynecologic cancers, several chemotherapy drugs can cause CIA. For instance, CIA occurred in 80–100% of cases with paclitaxel or docetaxel, 60–100% with topotecan or etoposide, and over 60% with cisplatin, carboplatin, or ifosfamide2,4. Using the Hospital Anxiety and Depression Scale (HADS), our previous study showed that about 25% of patients receiving chemotherapy had poor self-image and depression due to CIA5. Therefore, the physical, psychological, and social impact of CIA cannot be underestimated.  \nScalp compression, topical calcitriol, topical minoxidil, alpha-tocopherol and herbal remedies have been studied for CIA prevention4. However, these approaches have shown inconsistent efficacy and have not been  \n1Division of Gynaecological Oncology, Department of Obstetrics & Gynaecology, Queen Mary Hospital, Pokfulam, Hong Kong SAR. 2Department of Obstetrics & Gynaecology, School of Clinical Medicine, The University of Hong Kong, 6/F Professorial Block, Pokfulam, Hong Kong SAR. 3Division of Clinical Psychology, Queen Mary Hospital, Pokfulam, Hong Kong SAR. 4Department of Psychiatry, The University of Hong Kong, Pokfulam, Hong Kong SAR.  \n5Dermatology Division, Department of Medicine, Queen Mary ","cbCaip1FYlZ5vtGp","https://ap.wps.com/l/cbCaip1FYlZ5vtGp","pdf",2083695,11,"English","# Methods\n## Study design\n# Results\n## Primary endpoint: hair preservation\n## Secondary outcomes: quality of life, psychological distress, and safety\n# Discussion\n## Clinical implications and future directions","[{\"question\":\"What was the primary goal of the study?\",\"answer\":\"To assess whether scalp cooling can improve hair preservation after completion of chemotherapy in women with primary gynecologic cancers.\"},{\"question\":\"How were participants assigned to treatment groups?\",\"answer\":\"Women planning 3-weekly carboplatin and paclitaxel were randomized 1:1 to scalp cooling or usual clinical practice.\"},{\"question\":\"What effects did scalp cooling have on psychological outcomes?\",\"answer\":\"Compared with usual practice, the scalp cooling group showed a lower incidence of psychological distress after cycle 2 and lower median PHQ-ADS scores after cycle 2 and 2–3 weeks post-chemotherapy.\"}]","The efficacy of scalp cooling in patients receiving chemotherapy for primary gynecologic cancers: a randomized controlled trial | PDF",1790094828,28,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c24c685eaf00e3c41c702164e2e27953.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/77f78b325863e8790a25417efbfd0a98.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d46525a6614622c718c863657cc4da4d.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f2bce8040a309a7eed5f714f019c4f18.webp",980,1287]